FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

410861007: Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2466312019 Carbidopa 12.5mg/levodopa 50mg/entacapone 200mg tablet (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
2472512016 Carbidopa 12.5mg/levodopa 50mg/entacapone 200mg tablet en Synonym Inactive Only initial character case insensitive SNOMED CT core module
2478140014 Levodopa 50mg/carbidopa 12.5mg/entacapone 200mg tablet en Synonym Inactive Only initial character case insensitive SNOMED CT core module
3486785018 Product containing carbidopa 12.5 mg and levodopa 50 mg and entacapone 200 mg/1 each oral tablet (clinical drug) en Fully specified name Inactive Entire term case insensitive SNOMED CT core module
3495134012 Product containing carbidopa 12.5 mg and levodopa 50 mg and entacapone 200 mg/1 each oral tablet en Synonym Inactive Entire term case insensitive SNOMED CT core module
3501954013 Carbidopa 12.5 mg and levodopa 50 mg and entacapone 200 mg oral tablet en Synonym Inactive Entire term case insensitive SNOMED CT core module
3569996017 Product containing only carbidopa 12.5 mg and levodopa 50 mg and entacapone 200 mg/1 each oral tablet en Synonym Inactive Entire term case insensitive SNOMED CT core module
3569997014 Product containing only carbidopa 12.5 mg and levodopa 50 mg and entacapone 200 mg/1 each oral tablet (clinical drug) en Fully specified name Inactive Entire term case insensitive SNOMED CT core module
3677285011 Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
3677286012 Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3677287015 Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet en Synonym Inactive Entire term case insensitive SNOMED CT core module
108359801000001111 Carbidopa 12.5 mg and levodopa 50 mg and entacapone 200 mg oral tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module


13 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Is a Product containing carbidopa and entacapone and levodopa false Inferred relationship Existential restriction modifier
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has active ingredient Entacapone false Inferred relationship Existential restriction modifier
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has active ingredient Levodopa false Inferred relationship Existential restriction modifier
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has active ingredient Carbidopa false Inferred relationship Existential restriction modifier
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Is a Product manufactured as oral dose form false Inferred relationship Existential restriction modifier
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has basis of strength substance Levodopa true Inferred relationship Existential restriction modifier 2
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has presentation strength numerator value 50 false Inferred relationship Existential restriction modifier 2
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 2
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 2
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 2
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has active ingredient Entacapone false Inferred relationship Existential restriction modifier 3
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has basis of strength substance Entacapone false Inferred relationship Existential restriction modifier 3
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has presentation strength numerator value 200 false Inferred relationship Existential restriction modifier 3
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 3
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 3
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 3
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has basis of strength substance Entacapone true Inferred relationship Existential restriction modifier 1
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has presentation strength numerator value 200 false Inferred relationship Existential restriction modifier 1
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has basis of strength substance Carbidopa true Inferred relationship Existential restriction modifier 3
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has presentation strength numerator value 12.5 false Inferred relationship Existential restriction modifier 3
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has active ingredient Levodopa false Inferred relationship Existential restriction modifier 1
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has basis of strength substance Levodopa false Inferred relationship Existential restriction modifier 1
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has presentation strength numerator value 50 false Inferred relationship Existential restriction modifier 1
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has active ingredient Carbidopa false Inferred relationship Existential restriction modifier 2
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has basis of strength substance Carbidopa false Inferred relationship Existential restriction modifier 2
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has presentation strength numerator value 12.5 false Inferred relationship Existential restriction modifier 2
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has precise active ingredient Carbidopa true Inferred relationship Existential restriction modifier 3
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has unit of presentation Tablet true Inferred relationship Existential restriction modifier
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Is a Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has precise active ingredient Entacapone true Inferred relationship Existential restriction modifier 1
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has precise active ingredient Levodopa true Inferred relationship Existential restriction modifier 2
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Count of base of active ingredient 3 false Inferred relationship Existential restriction modifier
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Is a Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form) true Inferred relationship Existential restriction modifier
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Plays role Antiparkinson therapeutic role true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Generic Stalevo 50mg/12.5mg/200mg tablets Is a True Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start